DYN
Price
$9.57
Change
-$0.48 (-4.78%)
Updated
Jun 27 closing price
Capitalization
1.09B
32 days until earnings call
IGMS
Price
$1.22
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
64.92M
42 days until earnings call
Interact to see
Advertisement

DYN vs IGMS

Header iconDYN vs IGMS Comparison
Open Charts DYN vs IGMSBanner chart's image
Dyne Therapeutics
Price$9.57
Change-$0.48 (-4.78%)
Volume$4.65M
Capitalization1.09B
IGM Biosciences
Price$1.22
Change-$0.00 (-0.00%)
Volume$13
Capitalization64.92M
DYN vs IGMS Comparison Chart in %
Loading...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DYN vs. IGMS commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYN is a Buy and IGMS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (DYN: $9.57 vs. IGMS: $1.22)
Brand notoriety: DYN and IGMS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DYN: 175% vs. IGMS: 0%
Market capitalization -- DYN: $1.09B vs. IGMS: $64.92M
DYN [@Biotechnology] is valued at $1.09B. IGMS’s [@Biotechnology] market capitalization is $64.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYN’s FA Score shows that 1 FA rating(s) are green whileIGMS’s FA Score has 0 green FA rating(s).

  • DYN’s FA Score: 1 green, 4 red.
  • IGMS’s FA Score: 0 green, 5 red.
According to our system of comparison, DYN is a better buy in the long-term than IGMS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYN’s TA Score shows that 4 TA indicator(s) are bullish while IGMS’s TA Score has 3 bullish TA indicator(s).

  • DYN’s TA Score: 4 bullish, 5 bearish.
  • IGMS’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, DYN is a better buy in the short-term than IGMS.

Price Growth

DYN (@Biotechnology) experienced а -7.27% price change this week, while IGMS (@Biotechnology) price change was +4.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

DYN is expected to report earnings on Jul 31, 2025.

IGMS is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DYN($1.09B) has a higher market cap than IGMS($64.9M). DYN YTD gains are higher at: -59.380 vs. IGMS (-80.033). IGMS has higher annual earnings (EBITDA): -178.4M vs. DYN (-395.31M). DYN has more cash in the bank: 677M vs. IGMS (152M). DYN has less debt than IGMS: DYN (23.3M) vs IGMS (44M). IGMS has higher revenues than DYN: IGMS (2.68M) vs DYN (0).
DYNIGMSDYN / IGMS
Capitalization1.09B64.9M1,673%
EBITDA-395.31M-178.4M222%
Gain YTD-59.380-80.03374%
P/E RatioN/AN/A-
Revenue02.68M-
Total Cash677M152M445%
Total Debt23.3M44M53%
TECHNICAL ANALYSIS
Technical Analysis
DYNIGMS
RSI
ODDS (%)
Bullish Trend 3 days ago
89%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
71%
Bearish Trend 3 days ago
88%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IGMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RPGRF149.00N/A
N/A
REA Group Ltd
PWFNF16.03N/A
N/A
Power Financial Corp.
ERLFF1.50-0.01
-0.99%
Entree Resources Ltd.
APGOF0.25-0.01
-4.24%
Apollo Silver Corp.
NLLSF0.24-0.02
-8.75%
Nel ASA

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with RNA. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
-4.78%
RNA - DYN
56%
Loosely correlated
-2.68%
CRNX - DYN
55%
Loosely correlated
-0.10%
XNCR - DYN
52%
Loosely correlated
-3.10%
APGE - DYN
50%
Loosely correlated
N/A
ERAS - DYN
49%
Loosely correlated
N/A
More

IGMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, IGMS has been loosely correlated with MRSN. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if IGMS jumps, then MRSN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGMS
1D Price
Change %
IGMS100%
N/A
MRSN - IGMS
56%
Loosely correlated
-10.46%
CRNX - IGMS
50%
Loosely correlated
-0.10%
DYN - IGMS
48%
Loosely correlated
-4.78%
APGE - IGMS
43%
Loosely correlated
N/A
FATE - IGMS
41%
Loosely correlated
-5.45%
More